Company
Lantern Pharma
Drug development platform
Updated by Gregslist · Sep 19, 2026 · Report a correction
About
Lantern Pharma develops cancer drug candidates for patients whose tumor biology may make them responsive to particular treatments. Its RADR platform analyzes genomic, clinical and drug-response data to select compounds, explore drug combinations and identify patient groups for clinical trials.
Leaders
Key facts
- Region
- Dallas
- Dallas relationship
- Headquartered in Dallas
- Headquarters
- Dallas, TX
- Employees
- Small · 11–50 employees
- Founded
- 2013
- Vertical industry
- Healthcare
- Category
- Data & Analytics
- Total funding
- $3.7M
- Funding type
- Public
Funding history
| Date | Round | Amount | Investors |
|---|---|---|---|
| May 2, 2017 | Series A | $3.7M | Bios PartnersleadGreen Park & Golf Ventureslead |
Frequently asked questions about Lantern Pharma
Where is Lantern Pharma headquartered?
Lantern Pharma is headquartered in Dallas, TX.
When was Lantern Pharma founded?
Lantern Pharma was founded in 2013.
How much funding has Lantern Pharma raised?
Lantern Pharma has raised $3.7M in verified disclosed funding across all rounds tracked on Gregslist Dallas.
